3. Duplicative Therapy

Concurrent administration of multiple immune globulins does not provide additional therapeutic benefit and is not recommended. However, adjunctive administration of an immune globulin and a hyperimmune globulin could potentially be necessary in certain circumstances. Patient profiles containing concomitant prescriptions for two or more immune globulin products will be reviewed.